AMLODIPINE BESYLATE AND VALSARTAN Drug Patent Profile
✉ Email this page to a colleague
When do Amlodipine Besylate And Valsartan patents expire, and what generic alternatives are available?
Amlodipine Besylate And Valsartan is a drug marketed by Alembic, Aurobindo Pharma, Hetero Labs, Lupin, Mylan, Novel Labs Inc, Strides Pharma, Teva Pharms Usa, and Torrent. and is included in nine NDAs.
The generic ingredient in AMLODIPINE BESYLATE AND VALSARTAN is amlodipine besylate; valsartan. There are fifty drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the amlodipine besylate; valsartan profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Amlodipine Besylate And Valsartan
A generic version of AMLODIPINE BESYLATE AND VALSARTAN was approved as amlodipine besylate; valsartan by STRIDES PHARMA on March 28th, 2013.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AMLODIPINE BESYLATE AND VALSARTAN?
- What are the global sales for AMLODIPINE BESYLATE AND VALSARTAN?
- What is Average Wholesale Price for AMLODIPINE BESYLATE AND VALSARTAN?
Summary for AMLODIPINE BESYLATE AND VALSARTAN
US Patents: | 0 |
Applicants: | 9 |
NDAs: | 9 |
Finished Product Suppliers / Packagers: | 8 |
Clinical Trials: | 3 |
DailyMed Link: | AMLODIPINE BESYLATE AND VALSARTAN at DailyMed |